OpenAI Researcher’s AI Drug Discovery Startup Nears $2B Valuation Amid Investor Surge
Miles Wang, an OpenAI researcher, is in talks to launch an AI-driven drug discovery startup valued at $2 billion, signaling strong investor appetite for AI applications in life sciences.